General Mills Equity Method Investments increased by 8.5% to $431.90M in Q1 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Equity Method Investments shows a downward trend with a -5.6% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $513.80M | $462.00M | $397.90M | $431.90M |
| QoQ Change | — | -10.1% | -13.9% | +8.5% |
| YoY Change | — | -10.1% | -13.9% | +8.5% |